Literature DB >> 22869790

The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.

Oliver Weigert1, David M Weinstock.   

Abstract

Recent genomic studies have outlined a landscape of recurrent alterations within some subtypes of lymphoid cancer. Yet, the timing and cellular contexts during which these alterations occur (ie, the molecular ontogeny) remain poorly understood. Lymphoid malignancies offer an exceptional opportunity to delineate the ontogeny of somatic alterations, as lymphocyte differentiation absolutely requires the introduction of indelible genetic rearrangements at antigen receptor loci during specific stages of maturation. We review competing models of lymphomagenesis and highlight evolving evidence that somatic alterations in uncommitted hematopoietic progenitors contribute to some mature lymphoid neoplasms. These progenitors could serve as reservoirs for further clonal evolution and thereby contribute to therapeutic resistance, tumor relapse, and the development of second hematologic malignancies. Defining the pathways that are dysregulated within early progenitors and the ontogeny of subsequent alterations that contribute to lymphoid transformation could establish novel therapeutic targets across a variety of hematologic malignancies and even guide avenues for future preventive strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22869790     DOI: 10.1182/blood-2012-05-414995

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Clonal hematopoiesis.

Authors:  Max Jan; Benjamin L Ebert; Siddhartha Jaiswal
Journal:  Semin Hematol       Date:  2016-10-20       Impact factor: 3.851

2.  Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.

Authors:  Phuong Vo; Elaine S Jaffe; Lisa Cook; Catalina Ramos; Richard Childs
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-08-30

Review 3.  Mechanisms determining the fate of hematopoietic stem cells.

Authors:  Shouheng Lin; Ruocong Zhao; Yiren Xiao; Peng Li
Journal:  Stem Cell Investig       Date:  2015-05-15

Review 4.  Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2015-02-03       Impact factor: 2.490

Review 5.  How we manage follicular lymphoma.

Authors:  W Hiddemann; B D Cheson
Journal:  Leukemia       Date:  2014-02-28       Impact factor: 11.528

6.  Impact of age on genetics and treatment efficacy in follicular lymphoma.

Authors:  Stefan Alig; Vindi Jurinovic; Alessandro Pastore; Deepak Bararia; Sarah Häbe; Johannes C Hellmuth; Robert Kridel; Randy Gascoyne; Christian Schmidt; Anna-Katharina Zöllner; Christian Buske; Martin Dreyling; Michael Unterhalt; Wolfgang Hiddemann; Eva Hoster; Oliver Weigert
Journal:  Haematologica       Date:  2018-03-15       Impact factor: 9.941

Review 7.  Nature and importance of follicular lymphoma precursors.

Authors:  Emilie Mamessier; Florence Broussais-Guillaumot; Bruno Chetaille; Reda Bouabdallah; Luc Xerri; Elaine S Jaffe; Bertrand Nadel
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

Review 8.  Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.

Authors:  Koorosh Korfi; Sara Ali; James A Heward; Jude Fitzgibbon
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

9.  Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.

Authors:  Claudia Lentucci; Anna C Belkina; Carly T Cederquist; Michelle Chan; Holly E Johnson; Sherry Prasad; Amanda Lopacinski; Barbara S Nikolajczyk; Stefano Monti; Jennifer Snyder-Cappione; Bogdan Tanasa; M Dafne Cardamone; Valentina Perissi
Journal:  J Biol Chem       Date:  2016-12-30       Impact factor: 5.157

10.  Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells.

Authors:  Sabina Swierczek; Jitka Nausova; Jaroslav Jelinek; Enli Liu; Paul Roda; Jana Kucerova; Marie Jarosova; Helena Urbankova; Karel Indrak; Josef T Prchal; Vladimir Divoky
Journal:  Am J Hematol       Date:  2012-12-24       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.